| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Neil William Aubuchon is Chief Commercial Officer at VKTX. Neil William Aubuchon's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $117K at current prices.
Net of sales, the VKTX filings show accumulation of 4,475 shares.
Neil William Aubuchon has 2 Form 4 filings on record from January 2026 to March 2026, all as Chief Commercial Officer at Viking Therapeutics (VKTX), 2026.
The 2 reported transactions were 1 open-market purchase and 1 option or other derivative award.
Counted by filing, the open-market trades come to 1 purchase worth about $150K and no sales.
The only open-market purchase was 4,475 shares of VKTX at an average $33.50 on March 10, 2026, about $150K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | VKTX Viking Therapeutics, Inc. | Chief Commercial Officer | Buy | 4,475 | $33.50 | $149,912.50 | New | -15.6% | - |